In Silico and In Vivo Evaluation of microRNA-181c-5p’s Role in Hepatocellular Carcinoma
Open Access
Abstract
Hepatocellular carcinoma (HCC) is a fatal disease, accounting for 75–85% of primary liver cancers. The conclusive research on miR-181c-5p’s role in hepatocarcinogenesis, whether it has oncogenic effects or acts as a tumor repressor, is limited and fluctuating. Therefore, the current study aimed to elucidate the role of miR-181c-5p in HCC in silico and in vivo. The bioinformatics analysis of miR-181c-5p expression data in HCC using several databases strongly shed light on its involvement in HCC development, but also confirmed the fluctuating data around its role. miR-181c-5p was proven here to have an oncogenic role by increasing HepG2 cells’ viability as confirmed by MTT analysis. In addition, miR-181c-5p was upregulated in the HCC positive control group and progressed the HCC development and malignant features by its forced expression in an HCC mouse model by targeted delivery using a LA-PAMAM polyplex. This is indicated by the cancerous gross and histological features, and the significant increase in liver function biomarkers. The functional enrichment bioinformatics analyses of miR-181c-5p-downregulated targets in HCC indicated that miR-181c-5p targets were significantly enriched in multiple pathways and biological processes involved in HCC development. Fbxl3, an example for miR-181c-5p potential targets, downregulation and its correlation with miR-181c-5p were validated by qPCR. In conclusion, miR-181c-5p is upregulated in HCC and has an oncogenic role enhancing HCC progression.Keywords
Funding Information
- Science and Technology Development Fund (18505, 12060165, 5202)
- National Research Centre (18505, 12060165, 5202)
- project prism (18505, 12060165, 5202)
This publication has 81 references indexed in Scilit:
- miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytesMitochondrion, 2012
- Dynamic Modulation of Thymic MicroRNAs in Response to StressPLOS ONE, 2011
- MicroRNA-143 Regulates Human Osteosarcoma Metastasis by Regulating Matrix Metalloprotease-13 ExpressionMolecular Therapy, 2011
- MicroRNA Profile Predicts Recurrence after Resection in Patients with Hepatocellular Carcinoma within the Milan CriteriaPLOS ONE, 2011
- Wnt/beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinomaCell & Bioscience, 2011
- Causes and consequences of microRNA dysregulation in cancerNature Reviews Genetics, 2009
- Identification of microRNA‐181 by genome‐wide screening as a critical player in EpCAM–positive hepatic cancer stem cells†Hepatology, 2009
- miR2Disease: a manually curated database for microRNA deregulation in human diseaseNucleic Acids Research, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006